A detailed history of New Edge Advisors, LLC transactions in Surmodics Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 994 shares of SRDX stock, worth $39,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
994
Previous 849 17.08%
Holding current value
$39,282
Previous $35,000 8.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$38.47 - $42.24 $5,578 - $6,124
145 Added 17.08%
994 $38,000
Q4 2023

Feb 13, 2024

BUY
$28.47 - $38.49 $2,847 - $3,849
100 Added 13.35%
849 $30,000
Q4 2022

Feb 14, 2023

BUY
$29.44 - $37.31 $22,050 - $27,945
749 New
749 $25,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $553M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.